Cigna Holding Co (CI) Director Sells $184,430.00 in Stock
Cigna Holding Co (NYSE:CI) Director John Partridge sold 1,000 shares of Cigna stock in a transaction dated Thursday, February 7th. The stock was sold at an average price of $184.43, for a total value of $184,430.00. The sale was disclosed in a filing with the SEC, which can be accessed through this link.
NYSE:CI traded up $1.52 during mid-day trading on Monday, reaching $182.89. 3,738,500 shares of the company’s stock traded hands, compared to its average volume of 2,945,721. Cigna Holding Co has a 12-month low of $163.02 and a 12-month high of $226.60. The company has a market cap of $44.16 billion, a PE ratio of 12.86, a P/E/G ratio of 0.90 and a beta of 0.72. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.42 and a quick ratio of 0.98.
Cigna (NYSE:CI) last announced its quarterly earnings results on Friday, February 1st. The health services provider reported $2.46 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.53 by ($0.07). Cigna had a net margin of 5.42% and a return on equity of 16.64%. The business had revenue of $13.75 billion for the quarter, compared to analysts’ expectations of $11.38 billion. During the same quarter in the prior year, the firm earned $1.94 EPS. The firm’s revenue for the quarter was up 29.3% on a year-over-year basis. Analysts expect that Cigna Holding Co will post 16.4 EPS for the current fiscal year.
CI has been the topic of several analyst reports. Zacks Investment Research reiterated a “strong-buy” rating and issued a $246.00 price objective on shares of Cigna in a report on Monday, November 12th. Leerink Swann lifted their price objective on Cigna from $250.00 to $260.00 and gave the stock an “outperform” rating in a report on Monday, November 19th. BMO Capital Markets lifted their price objective on Cigna from $220.00 to $230.00 and gave the stock a “hold” rating in a report on Friday, November 2nd. Barclays lifted their price objective on Cigna from $228.00 to $235.00 and gave the stock an “overweight” rating in a report on Friday, November 2nd. Finally, Citigroup lifted their price objective on Cigna from $243.00 to $249.00 and gave the stock a “buy” rating in a report on Friday, November 2nd. Four analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $229.09.
WARNING: This story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2019/02/11/cigna-holding-co-ci-director-sells-184430-00-in-stock.html.
Cigna Company Profile
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers.
Featured Article: No Load Funds
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.